Saadh M, Hussain Q, Alazzawi T, Fahdil A, Athab Z, Yarmukhamedov B
Biochem Genet. 2024; .
PMID: 39103713
DOI: 10.1007/s10528-024-10897-0.
Altalebi S, Haghi M, Feizi M
Mol Biol Rep. 2023; 50(12):9825-9831.
PMID: 37840066
DOI: 10.1007/s11033-023-08801-x.
Zhang Q, Lin Z, Chen J, Zheng W
Int J Ophthalmol. 2021; 14(1):32-41.
PMID: 33469481
PMC: 7790682.
DOI: 10.18240/ijo.2021.01.05.
Jinesh G, Napoli M, Ackerman H, Raulji P, Montey N, Flores E
Sci Rep. 2020; 10(1):12371.
PMID: 32704163
PMC: 7378193.
DOI: 10.1038/s41598-020-69179-5.
Gao L, Xiong X
Int J Clin Exp Pathol. 2020; 11(9):4374-4384.
PMID: 31949834
PMC: 6962943.
Bioinformatics Analysis Identifies MicroRNAs and Target Genes Associated with Prognosis in Patients with Melanoma.
Li Q, Zhang L, Wu S, Huang C, Liu J, Wang P
Med Sci Monit. 2019; 25:7784-7794.
PMID: 31621692
PMC: 6820336.
DOI: 10.12659/MSM.917082.
Contextual Regulation of TGF-β Signaling in Liver Cancer.
Tu S, Huang W, Huang C, Luo Z, Yan X
Cells. 2019; 8(10).
PMID: 31614569
PMC: 6829617.
DOI: 10.3390/cells8101235.
miRNA-20b inhibits cerebral ischemia-induced inflammation through targeting NLRP3.
Zhao J, Wang H, Dong L, Sun S, Li L
Int J Mol Med. 2019; 43(3):1167-1178.
PMID: 30628668
PMC: 6365032.
DOI: 10.3892/ijmm.2018.4043.
MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.
Qu W, Wen X, Su K, Gou W
J Cell Mol Med. 2019; 23(2):1541-1552.
PMID: 30597727
PMC: 6349347.
DOI: 10.1111/jcmm.14062.
Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during Human Hepatic Fibrocarcinogenesis.
Yoshida K, Matsuzaki K, Murata M, Yamaguchi T, Suwa K, Okazaki K
Cancers (Basel). 2018; 10(6).
PMID: 29874844
PMC: 6025395.
DOI: 10.3390/cancers10060183.
MicroRNA-124-3p directly targets PDCD6 to inhibit metastasis in breast cancer.
Zhang L, Chen X, Liu B, Han J
Oncol Lett. 2018; 15(1):984-990.
PMID: 29387242
PMC: 5769374.
DOI: 10.3892/ol.2017.7358.
Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.
Zhang Y, Wei C, Guo C, Bi R, Xie J, Guan D
Oncotarget. 2018; 8(63):107237-107257.
PMID: 29291025
PMC: 5739810.
DOI: 10.18632/oncotarget.20883.
Selective activation of miRNAs of the primate-specific chromosome 19 miRNA cluster (C19MC) in cancer and stem cells and possible contribution to regulation of apoptosis.
Nguyen P, Huang C, Sugii S, Cheong S, Choo K
J Biomed Sci. 2017; 24(1):20.
PMID: 28270145
PMC: 5341377.
DOI: 10.1186/s12929-017-0326-z.
MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.
Zhuang L, Yang Y, Ma X, Han B, Wang Z, Zhao Q
Cell Death Dis. 2016; 7:e2203.
PMID: 27100897
PMC: 4855645.
DOI: 10.1038/cddis.2016.100.
MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.
Zhang J, Liu L, Sun Y, Xiang J, Zhou D, Wang L
Oncotarget. 2016; 7(18):26516-34.
PMID: 27049921
PMC: 5041996.
DOI: 10.18632/oncotarget.8530.
MiR-519d facilitates the progression and metastasis of cervical cancer through direct targeting Smad7.
Zhou J, Zheng S, Liu J, Shi R, Yu H, Wei M
Cancer Cell Int. 2016; 16:21.
PMID: 27006642
PMC: 4802873.
DOI: 10.1186/s12935-016-0298-1.
SMAD7 loci contribute to risk of hepatocellular carcinoma and clinicopathologic development among Chinese Han population.
Ji J, Xu M, Zhao Z, Tu J, Gao J, Lu C
Oncotarget. 2016; 7(16):22186-92.
PMID: 26989026
PMC: 5008354.
DOI: 10.18632/oncotarget.8065.
Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1.
Kumar P, Sharad S, Petrovics G, Mohamed A, Dobi A, Sreenath T
Oncotarget. 2016; 7(16):22791-806.
PMID: 26988912
PMC: 5008401.
DOI: 10.18632/oncotarget.8061.
Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.
Chen W, Chen L, Cai Z, Liang D, Zhao B, Zeng Y
Tumour Biol. 2016; 37(7):9343-55.
PMID: 26779633
DOI: 10.1007/s13277-016-4823-6.
CRCT1 regulated by microRNA-520 g inhibits proliferation and induces apoptosis in esophageal squamous cell cancer.
Wu N, Song Y, Pang L, Chen Z
Tumour Biol. 2016; 37(6):8271-9.
PMID: 26718216
DOI: 10.1007/s13277-015-4730-2.